Declan Doogan - 09 Jan 2026 Form 4 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Jan 2026, 20:03:44 UTC
Prior SEC filing
03 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ S. Halle Vakani, as Attorney-in-Fact

Key filing fact

Declan Doogan filed Form 4 for TENAX THERAPEUTICS, INC. (TENX) on 13 Jan 2026.

Key facts

  • This page summarizes Declan Doogan's Form 4 filing for TENAX THERAPEUTICS, INC. (TENX).
  • 1 reported transaction and 5 derivative rows are listed below.
  • Accepted by SEC: 13 Jan 2026, 20:03.

Change

  • Previous filing in this sequence was filed on 03 Jul 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001704234 Primary reporting owner

Doogan Declan

Relationship
Director
Address
101 GLEN LENNOX DRIVE SUITE 300, CHAPEL HILL
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Signature date
13 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TENX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,274
Date
09 Jan 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TENX transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+30,000
Change %
Price
$0.000000
Shares after
30,000
Date
09 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,000
Exercise price
$13.30
TENX holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4
Date
09 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4
Exercise price
$3200.00
TENX holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4
Date
09 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4
Exercise price
$992.00
TENX holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
100,000
Date
09 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
100,000
Exercise price
$5.94
TENX holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
80,000
Date
09 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
80,000
Exercise price
$5.75
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .